MRVL Marvel Biosciences Corp.

0.0804USD0.1150 CAD · TSXV0.00%Mkt Cap: 5.92M USDP/E: —

Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated d…